{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:31:41Z","timestamp":1768779101191,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["26040"],"award-info":[{"award-number":["26040"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11046-022-00694-x","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T16:02:31Z","timestamp":1670688151000},"page":"9-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of Risk Factors and Clinical Outcomes in Hospitalized COVID-19 Patients with Candida spp. Co-infections: Species Distribution and Antifungal Susceptibility Patterns of Isolates"],"prefix":"10.1007","volume":"188","author":[{"given":"Somayeh","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Zare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Nikoupour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Arabsheybani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Jabrodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeel","family":"Eghtedarnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Chamanpara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Geramizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Anbardar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Malekizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Gashtasebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mohsenzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Shafiekhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamiar","family":"Zomorodian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"issue":"10229","key":"694_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"key":"694_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhin.2021.04.001","volume":"113","author":"DL Silva","year":"2021","unstructured":"Silva DL, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. J Hosp Infect. 2021;113:145\u201354.","journal-title":"J Hosp Infect"},{"issue":"1","key":"694_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-022-01763-9","volume":"19","author":"M Shafiekhani","year":"2022","unstructured":"Shafiekhani M, et al. Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study. Virol J. 2022;19(1):1\u20137.","journal-title":"Virol J."},{"issue":"4","key":"694_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/jof6040211","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, et al. COVID-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions? J Fungi. 2020;6(4):211.","journal-title":"J Fungi."},{"issue":"10223","key":"694_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"18","key":"694_CR6","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1007\/s00253-020-10814-6","volume":"104","author":"X Chen","year":"2020","unstructured":"Chen X, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104(18):7777\u201385.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"694_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","volume":"185","author":"G Song","year":"2020","unstructured":"Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185(4):599\u2013606.","journal-title":"Mycopathologia"},{"key":"694_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2020.05.004","volume":"56","author":"T Rolling","year":"2020","unstructured":"Rolling T, Hohl TM, Zhai B. Minority report: The intestinal mycobiota in systemic infections. Curr Opin Microbiol. 2020;56:1\u20136.","journal-title":"Curr Opin Microbiol"},{"key":"694_CR9","unstructured":"World health organization (WHO). WHO coronavirus (COVID-19) Dashboard [Internet]. Available from: https:\/\/covid19.who.int\/."},{"issue":"2","key":"694_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.13091","volume":"288","author":"G Pascarella","year":"2020","unstructured":"Pascarella G, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192\u2013206.","journal-title":"J Intern Med"},{"key":"694_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.micpath.2017.06.024","volume":"110","author":"M Jafari","year":"2017","unstructured":"Jafari M, et al. Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis. Microb Pathog. 2017;110:73\u20137.","journal-title":"Microb Pathog"},{"issue":"4","key":"694_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7883\/yoken.JJID.2005.235","volume":"58","author":"H Mirhendi","year":"2005","unstructured":"Mirhendi H, et al. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method. Jpn J Infect Dis. 2005;58(4):235.","journal-title":"Jpn J Infect Dis"},{"key":"694_CR13","unstructured":"Wayne, P., Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3 and Supplement S, 2008;3:6\u201312."},{"key":"694_CR14","unstructured":"Wayne, P., Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. CLSI document M27-A2, 2002."},{"key":"694_CR15","first-page":"M27","volume":"3","author":"P Wayne","year":"2008","unstructured":"Wayne P. Reference method for broth dilution antifungal susceptibility testing of yeasts. Clin Lab Standards Inst. 2008;3:M27\u201333.","journal-title":"Clin Lab Standards Inst."},{"key":"694_CR16","unstructured":"Clinical and L.S. Institute, Performance standards for antifungal susceptibility testing of yeasts. CLSI supplement M60, 2017."},{"key":"694_CR17","unstructured":"Clinical and L.S. Institute, Epidemiological cutoff values for antifungal susceptibility testing. 2016, Clinical and Laboratory Standards Institute Wayne, PA."},{"issue":"12","key":"694_CR18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"694_CR19","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/myc.13155","volume":"63","author":"I Falces-Romero","year":"2020","unstructured":"Falces-Romero I, et al. Isolation of Aspergillus spp. in respiratory samples of patients with COVID-19 in a Spanish tertiary care hospital. Mycoses. 2020;63(11):1144\u20138.","journal-title":"Mycoses"},{"issue":"9","key":"694_CR20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1017\/ice.2020.156","volume":"41","author":"P Zhou","year":"2020","unstructured":"Zhou P, et al. Bacterial and fungal infections in COVID-19 patients: a matter of concern. Infect Control Hosp Epidemiol. 2020;41(9):1124\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"694_CR21","first-page":"48","volume":"10","author":"C Norberg","year":"2021","unstructured":"Norberg C, et al. Candida infections associated with COVID-19: an underestimated risk. WJPPS. 2021;10(9):48\u201364.","journal-title":"WJPPS"},{"issue":"10","key":"694_CR22","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/cid\/ciaa524","volume":"71","author":"CJ Clancy","year":"2020","unstructured":"Clancy CJ, Nguyen MH. Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clin Infect Dis. 2020;71(10):2736\u201343.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"694_CR23","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig. 2020;130(5):2620\u20139.","journal-title":"J Clin Investig"},{"issue":"10223","key":"694_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"11","key":"694_CR25","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3201\/eid2611.203504","volume":"26","author":"A Chowdhary","year":"2020","unstructured":"Chowdhary A, et al. Multidrug-resistant Candida auris infections in critically Ill coronavirus disease patients, India, April\u2013July 2020. Emerg Infect Dis. 2020;26(11):2694.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"694_CR26","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1002\/jmv.26633","volume":"93","author":"E Bishburg","year":"2021","unstructured":"Bishburg E, et al. Fungemia in covid-19 ICU patients, a single medical center experience. J Med Virol. 2021;93(5):2810\u20134.","journal-title":"J Med Virol"},{"issue":"4","key":"694_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11046-020-00472-7","volume":"185","author":"M Salehi","year":"2020","unstructured":"Salehi M, et al. Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran. Mycopathologia. 2020;185(4):607\u201311.","journal-title":"Mycopathologia"},{"issue":"7","key":"694_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271333","volume":"17","author":"T Nazari","year":"2022","unstructured":"Nazari T, et al. COVID-19-associated fungal infections in Iran: A systematic review. PLoS ONE. 2022;17(7): e0271333.","journal-title":"PLoS ONE"},{"issue":"5","key":"694_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/cid\/ciab562","volume":"74","author":"EE Seagle","year":"2021","unstructured":"Seagle EE, et al. The landscape of candidemia during the COVID-19 pandemic. Clin Infect Dis. 2021;74(5):802\u201311.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"694_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/jof7070545","volume":"7","author":"OT Ezeokoli","year":"2021","unstructured":"Ezeokoli OT, Gcilitshana O, Pohl CH. Risk factors for fungal co-infections in critically ill COVID-19 patients, with a focus on immunosuppressants. J Fungi. 2021;7(7):545.","journal-title":"J Fungi."},{"issue":"7","key":"694_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102564","volume":"19","author":"S Antinori","year":"2020","unstructured":"Antinori S, et al. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Autoimmun Rev. 2020;19(7): 102564.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"694_CR32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/jof7070552","volume":"7","author":"M Kordalewska","year":"2021","unstructured":"Kordalewska M, et al. Antifungal drug susceptibility and genetic characterization of fungi recovered from COVID-19 patients. J Fungi. 2021;7(7):552.","journal-title":"J Fungi."},{"key":"694_CR33","doi-asserted-by":"crossref","unstructured":"Herc E et al. Characteristics and outcomes of COVID-19 patients with fungal infections. In: Open Forum Infectious Disease. Oxford University Press 2020.","DOI":"10.1093\/ofid\/ofaa439.561"},{"key":"694_CR34","doi-asserted-by":"publisher","first-page":"106619","DOI":"10.1016\/j.rmed.2021.106619","volume":"188","author":"G Segrelles-Calvo","year":"2021","unstructured":"Segrelles-Calvo G, et al. Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors. Respir Med. 2021;188:106619.","journal-title":"Respir Med"},{"issue":"6","key":"694_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/myc.13447","volume":"65","author":"K Vinayagamoorthy","year":"2022","unstructured":"Vinayagamoorthy K, Pentapati KC, Prakash H. Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID-19) patients: a systematic review. Mycoses. 2022;65(6):613\u201324.","journal-title":"Mycoses"},{"issue":"6","key":"694_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","volume":"220","author":"D Pittet","year":"1994","unstructured":"Pittet D, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751.","journal-title":"Ann Surg"},{"issue":"5","key":"694_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1365-2141.2005.05397.x","volume":"129","author":"S Shoham","year":"2005","unstructured":"Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol. 2005;129(5):569\u201382.","journal-title":"Br J Haematol"},{"issue":"22","key":"694_CR38","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2174\/156802662022200917110102","volume":"20","author":"LN Silva","year":"2020","unstructured":"Silva LN, et al. Fungal infections in COVID-19-positive patients: a lack of optimal treatment options. Curr Top Med Chem. 2020;20(22):1951\u20137.","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"694_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11046-022-00637-6","volume":"187","author":"JL Benelli","year":"2022","unstructured":"Benelli JL, et al. Fungal bloodstream co-infection by trichosporon asahii in a COVID-19 critical patient: case report and literature review. Mycopathologia. 2022;187(4):397\u2013404.","journal-title":"Mycopathologia"},{"issue":"3","key":"694_CR40","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jmv.26441","volume":"93","author":"A Goncalves Mendes Neto","year":"2021","unstructured":"Goncalves Mendes Neto A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2021;93(3):1489\u201395.","journal-title":"J Med Virol"},{"key":"694_CR41","doi-asserted-by":"crossref","unstructured":"Riad A et al. Oral candidiasis in non\u2010severe COVID\u201019 patients: call for antibiotic stewardship. Oral Surg. 2020;15(3):465\u2013466.","DOI":"10.1111\/ors.12561"},{"issue":"4","key":"694_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000886","volume":"6","author":"DK Morales","year":"2010","unstructured":"Morales DK, Hogan DA. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog. 2010;6(4): e1000886.","journal-title":"PLoS Pathog"},{"issue":"8","key":"694_CR43","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.3390\/ijerph18084358","volume":"18","author":"R Cultrera","year":"2021","unstructured":"Cultrera R, et al. Co-infections in critically ill patients with or without COVID-19: a comparison of clinical microbial culture findings. Int J Environ Res Public Health. 2021;18(8):4358.","journal-title":"Int J Environ Res Public Health"},{"issue":"S1","key":"694_CR44","doi-asserted-by":"publisher","first-page":"s58","DOI":"10.1017\/ash.2021.112","volume":"1","author":"AB Cruz","year":"2021","unstructured":"Cruz AB, LeRose J, Chopra T. Comparison of Outcomes in Candidemia Between COVID-19 and Non\u2013COVID-19 Patients. Antimicrob Steward Healthc Epidemiol. 2021;1(S1):s58\u2013s58.","journal-title":"Antimicrob Steward Healthc Epidemiol."},{"issue":"9","key":"694_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/myc.13332","volume":"64","author":"B Kayaaslan","year":"2021","unstructured":"Kayaaslan B, et al. Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients. Mycoses. 2021;64(9):1083\u201391.","journal-title":"Mycoses"},{"issue":"1","key":"694_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/jac\/dky389","volume":"74","author":"L Whitney","year":"2019","unstructured":"Whitney L, et al. Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010\u201316. J Antimicrob Chemother. 2019;74(1):234\u201341.","journal-title":"J Antimicrob Chemother"},{"issue":"12b","key":"694_CR47","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/imj.12596","volume":"44","author":"C Morrissey","year":"2014","unstructured":"Morrissey C, et al. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J. 2014;44(12b):1298\u2013314.","journal-title":"Intern Med J"},{"issue":"3","key":"694_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/jof6030098","volume":"6","author":"I Ventoulis","year":"2020","unstructured":"Ventoulis I, et al. Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J Fungi. 2020;6(3):98.","journal-title":"J Fungi."},{"issue":"7","key":"694_CR49","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","volume":"73","author":"PL White","year":"2021","unstructured":"White PL, et al. A national strategy to diagnose coronavirus disease 2019\u2013associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2021;73(7):e1634\u201344.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"694_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/jof6030163","volume":"6","author":"B Posteraro","year":"2020","unstructured":"Posteraro B, et al. Pan-echinocandin-resistant Candida glabrata bloodstream infection complicating COVID-19: a fatal case report. J Fungi. 2020;6(3):163.","journal-title":"J Fungi."},{"issue":"2","key":"694_CR51","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.jinf.2020.08.005","volume":"82","author":"AM Al-Hatmi","year":"2021","unstructured":"Al-Hatmi AM, et al. COVID-19 associated invasive candidiasis. J Infect. 2021;82(2):e45\u20136.","journal-title":"J Infect"},{"key":"694_CR52","doi-asserted-by":"crossref","unstructured":"White PL et al. Candidemia in Coronavirus Disease 2019: A Link to Disease Pathology or Increased Clinical Pressures? Clin Infect Dis. 2020;73(9):e2839\u20132841","DOI":"10.1093\/cid\/ciaa1597"},{"issue":"4","key":"694_CR53","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/jof7040280","volume":"7","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar A, et al. Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J Fungi. 2021;7(4):280.","journal-title":"J Fungi"},{"issue":"8","key":"694_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/myc.13137","volume":"63","author":"M Salehi","year":"2020","unstructured":"Salehi M, et al. Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses. 2020;63(8):771\u20138.","journal-title":"Mycoses"},{"issue":"15","key":"694_CR55","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445\u201356.","journal-title":"N Engl J Med"},{"issue":"5","key":"694_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cmi.2020.12.030","volume":"27","author":"H Villanueva-Lozano","year":"2021","unstructured":"Villanueva-Lozano H, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect. 2021;27(5):813\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"694_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/jof7030220","volume":"7","author":"JND Almeida","year":"2021","unstructured":"Almeida JND, et al. Emergence of Candida auris in Brazil in a COVID-19 intensive care unit. J Fungi. 2021;7(3):220.","journal-title":"J Fungi."},{"issue":"6","key":"694_CR58","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/mmy\/myaa092","volume":"59","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar A, et al. Clinical and microbiological features of candiduria in critically ill adult patients in Shiraz, Iran (2016\u20132018): Deviations from international guidelines and fluconazole therapeutic failure. Med Mycol. 2021;59(6):600\u20137.","journal-title":"Med Mycol"},{"issue":"5","key":"694_CR59","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/mmy\/myaa059","volume":"59","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar A, et al. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016\u20132018). Med Mycol. 2021;59(5):422\u201330.","journal-title":"Med Mycol"},{"issue":"7","key":"694_CR60","doi-asserted-by":"publisher","first-page":"e02503","DOI":"10.1128\/AAC.02503-18","volume":"63","author":"A Arastehfar","year":"2019","unstructured":"Arastehfar A, et al. Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1. Antimicrob Agents Chemother. 2019;63(7):e02503-e2518.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"694_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.riam.2018.01.002","volume":"35","author":"S Amanloo","year":"2018","unstructured":"Amanloo S, et al. Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin. Rev Iberoam Micol. 2018;35(2):88\u201391.","journal-title":"Rev Iberoam Micol"},{"issue":"5","key":"694_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.26719\/2011.17.5.425","volume":"17","author":"P Badiee","year":"2011","unstructured":"Badiee P, et al. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. East Mediterr Health J. 2011;17(5):425\u201330.","journal-title":"East Mediterr Health J"},{"key":"694_CR63","doi-asserted-by":"crossref","unstructured":"Haddadi P et al. Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia. Jundishapur J Microbiol. 2014;7(9): e11858","DOI":"10.5812\/jjm.11858"},{"key":"694_CR64","unstructured":"Badiei P et al. Molecular identification and in-vitro susceptibility of Candida albicans and C. dubliniensis isolated from immunocompromised patients. 2009."},{"key":"694_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105520","volume":"166","author":"M Erami","year":"2022","unstructured":"Erami M, et al. Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia. Microb Pathog. 2022;166: 105520.","journal-title":"Microb Pathog"},{"issue":"1","key":"694_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2825-7","volume":"17","author":"P Badiee","year":"2017","unstructured":"Badiee P, et al. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates. BMC Infect Dis. 2017;17(1):1\u20138.","journal-title":"BMC Infect Dis"},{"key":"694_CR67","doi-asserted-by":"crossref","unstructured":"Mahmoudabadi AZ, Rezaei-Matehkolaei A, Ghanavati F. The susceptibility patterns of Candida species isolated from urine samples to posaconazole and caspofungin. Jundishapur J Microbiol. 2015;8(3).","DOI":"10.5812\/jjm.24298"},{"issue":"1","key":"694_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11046-014-9772-2","volume":"178","author":"M Castanheira","year":"2014","unstructured":"Castanheira M, et al. Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values. Mycopathologia. 2014;178(1):1\u20139.","journal-title":"Mycopathologia"},{"key":"694_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jgar.2020.10.004","volume":"23","author":"MA Cataldo","year":"2020","unstructured":"Cataldo MA, et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming \u201ccollateral effect.\u201d J Glob Antimicrob Resist. 2020;23:290.","journal-title":"J Glob Antimicrob Resist."}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-022-00694-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-022-00694-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-022-00694-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T05:18:13Z","timestamp":1728537493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-022-00694-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":69,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1007\/s11046-022-00694-x","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,10]]},"assertion":[{"value":"2 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose<i>.<\/i>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}